Unilever strategy under scrutiny after short-lived GSK skirmish
Go back to Unilever strategy under scrutiny after short-lived GSK skirmish| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 49.24 -0.41 (0.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $49.65 | 52 Week High | $45.58 | |||
| Open | $49.49 | 52 Week Low | $37.82 | |||
| Day High | $49.50 | P/E | N/A | |||
| Day Low | $49.00 | EPS | $0.00 | |||
| Volume | 3,324,159 | |||||
| UNILEVER PLC (NYSE: UL) | Delayed: 62.54 +0.29 (0.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $62.25 | 52 Week High | $48.97 | |||
| Open | $62.05 | 52 Week Low | $39.06 | |||
| Day High | $62.56 | P/E | N/A | |||
| Day Low | $61.89 | EPS | $0.00 | |||
| Volume | 2,740,425 | |||||
